Clinical trial

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of…

NCT00274417 · Urology of Virginia, Other · Unknown status

Key facts

NCT number NCT00274417
Title Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
Official title A Randomized, Placebo-Controlled, Double-Blind Study of the Use of Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP Study)
Lead sponsor Urology of Virginia, Other
Collaborators GlaxoSmithKline Industry
Status Unknown status
Study type Interventional
Conditions Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Intervention type Drug
Interventions dutasteride
Enrollment 60
Start date Jan 1, 2006
Completion May 1, 2009
First posted Jan 10, 2006
Last update posted Apr 18, 2007
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies